1. Home
  2. WAVE vs ANVS Comparison

WAVE vs ANVS Comparison

Compare WAVE & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

N/A

Current Price

$3.54

Market Cap

47.5M

Sector

Utilities

ML Signal

N/A

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

N/A

Current Price

$0.74

Market Cap

48.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WAVE
ANVS
Founded
2011
2008
Country
Israel
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
48.2M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
WAVE
ANVS
Price
$3.54
$0.74
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
★ $14.75
$9.50
AVG Volume (30 Days)
9.8K
★ 3.1M
Earning Date
11-03-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.39
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.65
$0.62
52 Week High
$10.87
$5.50

Technical Indicators

Market Signals
Indicator
WAVE
ANVS
Relative Strength Index (RSI) 30.23 39.13
Support Level N/A $0.62
Resistance Level $4.92 $1.41
Average True Range (ATR) 0.38 0.15
MACD -0.04 -0.01
Stochastic Oscillator 7.30 15.78

Price Performance

Historical Comparison
WAVE
ANVS

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: